Alnylam Pharmaceuticals, Inc.ALNY announced positive initial data from an ongoing phase I study on ALN AS1 for the treatment of acute hepatic porphyries. The phase I study is being carried out in three parts A, B and C on
Forex – financial instrument.Forex news
Alnylam Pharmaceuticals, Inc.ALNY announced positive initial data from an ongoing phase I study on ALN AS1 for the treatment of acute hepatic porphyries. The phase I study is being carried out in three parts A, B and C on